153 related articles for article (PubMed ID: 21699818)
1. The appendix may protect against Clostridium difficile recurrence.
Im GY; Modayil RJ; Lin CT; Geier SJ; Katz DS; Feuerman M; Grendell JH
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1072-7. PubMed ID: 21699818
[TBL] [Abstract][Full Text] [Related]
2. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
[TBL] [Abstract][Full Text] [Related]
3. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.
Hu MY; Katchar K; Kyne L; Maroo S; Tummala S; Dreisbach V; Xu H; Leffler DA; Kelly CP
Gastroenterology; 2009 Apr; 136(4):1206-14. PubMed ID: 19162027
[TBL] [Abstract][Full Text] [Related]
4. Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence.
Islam J; Cheek E; Navani V; Rajkumar C; Cohen J; Llewelyn MJ
J Hosp Infect; 2013 Sep; 85(1):17-21. PubMed ID: 23910403
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
[TBL] [Abstract][Full Text] [Related]
6. Potential protective role of linezolid against Clostridium difficile infection.
Valerio M; Pedromingo M; Muñoz P; Alcalá L; Marin M; Peláez T; Giannella M; Bouza E
Int J Antimicrob Agents; 2012 May; 39(5):414-9. PubMed ID: 22445203
[TBL] [Abstract][Full Text] [Related]
7. Best strategies in recurrent or persistent Clostridium difficile infection.
Cocanour CS
Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
[TBL] [Abstract][Full Text] [Related]
8. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
[TBL] [Abstract][Full Text] [Related]
9. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
[TBL] [Abstract][Full Text] [Related]
10. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital.
Goorhuis A; Debast SB; Dutilh JC; van Kinschot CM; Harmanus C; Cannegieter SC; Hagen EC; Kuijper EJ
Clin Infect Dis; 2011 Nov; 53(9):860-9. PubMed ID: 21914851
[TBL] [Abstract][Full Text] [Related]
11. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
[TBL] [Abstract][Full Text] [Related]
12. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland.
Burns K; Morris-Downes M; Fawley WN; Smyth E; Wilcox MH; Fitzpatrick F
J Hosp Infect; 2010 Aug; 75(4):287-91. PubMed ID: 20621236
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors for Clostridium difficile infection in children.
Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile infection prevention: biotherapeutics, immunologics, and vaccines.
Gerding DN
Discov Med; 2012 Jan; 13(68):75-83. PubMed ID: 22284786
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.
Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC
J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428
[TBL] [Abstract][Full Text] [Related]
17. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
[TBL] [Abstract][Full Text] [Related]
18. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
[TBL] [Abstract][Full Text] [Related]
19. Predictors of serious complications due to Clostridium difficile infection.
Gujja D; Friedenberg FK
Aliment Pharmacol Ther; 2009 Mar; 29(6):635-42. PubMed ID: 19077106
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
